William Forbes

This inventor holds 28 USPTO granted patents and 30 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Gastrointestinal Disorders. Top assignees: Salix Pharmaceuticals, Inc., Napo Pharmaceuticals, Inc., Dr. Falk Pharma Gmbh. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Forbes. Retrieved from https://idiyas.com/inventor/william-forbes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 30)

% Patents Active = 96.4

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 9 (Patent Applications = 18)

Average Co-Inventor Count = 1.8

ph-index = 10

Forward Citations = 209(Granted Patents)

Company Filing History:

26 out of 65

Salix Pharmaceuticals, Inc.

patents

2 out of 15

Napo Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Hepatic Encephalopathy

Irritable Bowel Syndrome

Diarrhea Treatment

Microbiota

Bowel Diseases

HIV-Associated Diarrhea

Granulated Mesalamine

Travelers Diarrhea

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12697326 - Methods of treating hepatic encephalopathy (2026-08-04),

2. 12285414 - Methods of treating hepatic encephalopathy (2025-04-29),

3. 11779571 - Methods for treating irritable bowel syndrome (IBS) (2023-10-10),

4. 11633384 - Methods of treating hepatic encephalopathy (2023-04-25),

5. 11564912 - Methods for treating irritable bowel syndrome (IBS) (2023-01-31),

6. 10765667 - Methods for treating irritable bowel syndrome (IBS) (2020-09-08),

7. 10709694 - Methods of treating hepatic encephalopathy (2020-07-14),

8. 10493064 - IBS microbiota and uses thereof (2019-12-03),

9. 10456384 - Methods for treating irritable bowel syndrome (IBS) (2019-10-29),

10. 10335397 - Methods of treating hepatic encephalopathy (2019-07-02),

11. 10314828 - Methods of treating hepatic encephalopathy (2019-06-11),

12. 9949958 - Methods of treating hepatic encephalopathy (2018-04-24),

13. 9931325 - Methods for treating irritable bowel syndrome (IBS) (2018-04-03),

14. 9855254 - Methods of treating hepatic encephalopathy (2018-01-02),

15. 9629829 - Methods of treating hepatic encephalopathy (2017-04-25),

Title: Innovations by William Forbes in Medical Treatments

Introduction

William Forbes, a notable inventor based in Raleigh, NC, has made significant contributions to the field of medical treatments, particularly through his extensive portfolio of 26 patents. His innovative approaches to complex medical conditions have the potential to impact numerous lives positively.

Latest Patents

Among his latest patents, Forbes has developed groundbreaking methods for treating irritable bowel syndrome (IBS). These methods include new treatment protocols and kits specifically designed for females, older subjects, and non-white individuals. Additionally, he has focused on hepatic encephalopathy, detailing a treatment approach that utilizes gastrointestinal-specific antibiotics, with rifaximin being a key example. These patents highlight his commitment to addressing diverse medical needs through tailored therapies.

Career Highlights

Forbes has worked with esteemed organizations such as Salix Pharmaceuticals and Napo Pharmaceuticals, where he applied his expertise in pharmaceutical innovation. His tenure at these companies has been marked by a dedication to developing effective therapeutic solutions and advancing medical research.

Collaborations

Throughout his career, William Forbes has collaborated with talented individuals such as Enoch Bortey and Kunal Merchant. These collaborations have facilitated the development of innovative treatments and have enhanced the scope of research within the medical field.

Conclusion

William Forbes stands out as a visionary inventor whose work in medical treatment innovations continues to inspire and contribute significantly to healthcare. His patents reflect a deep understanding of patient needs and a commitment to advancing medical science.

Profile summary based on public USPTO records.